RVLP - RVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q1 2022 Results - Earnings Call Transcript

RVL Pharmaceuticals plc (RVLP) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Brian Markison – Chief Executive Officer Mike DePetris – Interim Chief Financial Officer JD Schaub – Chief Operational Officer Conference Call Participants Douglas Tsao – H.C Wainwright Louise Chen – Cantor Greg Fraser – Truist Securities Balaji Prasad – Barclays Presentation Operator Good morning everyone. My name is Bertney and I will be your conference operator. At this time I like to welcome everyone to the RVL Pharmaceuticals First Quarter 2022 Financial Results Call. All lines have been placed on mute prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. [Operator Instructions] Lisa Wilson Thank you, operator. Welcome to RVL Pharmaceuticals, first quarter 2022 financial results and commercial update call. This is Lisa Wilson, Investor Relations for RVL. With me on today's call

For further details see:

RVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q1 2022 Results - Earnings Call Transcript